DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar Award

Key Facts

Status: Forecasted

Posted date: June 18, 2026

Archive date: October 28, 2026

Close date: September 28, 2026

Opportunity ID: 362853

Opportunity number: HT942526KCRPAKCIECSA

Opportunity category: Discretionary

Agency name: Defense Health Agency Contracting Activity - DHACA

Agency code: DOD-AMRAA

Award floor: $0

Award ceiling: $0

Cost sharing required: No

Funding Instrument Types
  • Grant
Category of Funding Activity
  • Science and Technology and other Research and Development
Eligible Applicants
  • Unrestricted
Tools
Categories (use these for quoted searches)
  • agency_code:dod_amraa
  • category_of_funding_activity:science_and_technology_and_other_research_and_development
  • cost_sharing_or_matching_requirement:false
  • eligible_applicants:unrestricted
  • funding_instrument_type:grant
  • opportunity_category:discretionary
  • status:forecasted
Description

Summary: Initially created in fiscal year 2019 (FY19), the Kidney Cancer Research Program (KCRP) Academy of Kidney Cancer Investigators (AKCI) is a unique interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The Academy pairs Early Career Scholars (ECS) with established investigators (Designated Mentors) under the oversight of the AKCI Leadership Team, a Designated Mentor Panel, and the Kidney Cancer Patient Advocates Panel. The AKCI’s overarching goal is to conduct innovative and impactful kidney cancer research while also developing a vital resource, a network of highly productive kidney cancer researchers conducting cutting edge research that advances the state of the field in kidney cancer and leads to new treatments for individuals living with kidney cancer.Distinctive Features:· Early-Career Scholar: The FY26 KCRP AKCI-ECSA focuses on both the Scholar’sresearch and their career potential in the kidney cancer field.· Designated Mentor: The Designated Mentor must have a strong record of successful mentorship coupled with a strong record of funding (past and present) and publications in kidney cancer research.· Preliminary Data: Preliminary data to support the feasibility of the research and approaches are required; however, these data do not need to be derived from the kidney cancer research field.

DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar Award
Summary: Initially created in fiscal year 2019 (FY19), the Kidney Cancer Research Program (KCRP) Academy of Kidney Cancer Investigators (AKCI) is a unique interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The Academy pairs Early Career Scholars (ECS) with established investigators (Designated Mentors) under the oversight of the AKCI Leadership Team, a Designated Mentor Panel, and the Kidney Cancer Patient Advocates Panel. The AKCI’s overarching goal is to conduct innovative and impactful kidney cancer research while also developing a vital resource, a network of highly productive kidney cancer researchers conducting cutting edge research that advances the state of the field in kidney cancer and leads to new treatments for individuals living with kidney cancer.Distinctive Features:· Early-Career Scholar: The FY26 KCRP AKCI-ECSA focuses on both the Scholar’sresearch and their career potential in the kidney cancer field.· Designated Mentor: The Designated Mentor must have a strong record of successful mentorship coupled with a strong record of funding (past and present) and publications in kidney cancer research.· Preliminary Data: Preliminary data to support the feasibility of the research and approaches are required; however, these data do not need to be derived from the kidney cancer research field.
[Forecasted] DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar Award
Forecasted
Defense Health Agency Contracting Activity - DHACA
Science and Technology and other Research and Development
Grant
Unrestricted
2026-06-18